Cumulative risk of developing prostate cancer in men with low (≤2.0 ng/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan-Reference-Cited by-同舟云学术

Cumulative risk of developing prostate cancer in men with low (≤2.0 ng/mL) prostate-specific antigen levels: A population-based screening cohort study in Japan

Published:2013-12-23 Issue:6 Volume:21 Page:560-565
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:Int J Urol

Author:

Sawada Kiyoshi¹,Kitagawa Yasuhide¹,Ito Kazuto²,Takeda Yasuo³,Mizokami Atsushi¹,Namiki Mikio¹

Affiliation:

1. Department of Integrative Cancer Therapy and Urology; Graduate School of Medical Science; , Kanazawa University; Kanazawa Ishikawa Japan

2. Department of Urology; Gunma University Graduate School of Medicine; Maebashi Gunma Japan

3. Kanazawa Medical Association; Kanazawa Ishikawa Japan

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.12380/fullpdf

Reference16 articles.

1. Prostate-cancer mortality at 11 years of follow-up;Schröder;N. Engl. J. Med.,2012

2. Mortality results from the Göteborg randomised population-based prostate-cancer screening trial;Hugosson;Lancet Oncol.,2010

3. Clinical outcomes of prostate cancer patients detected by prostate-specific antigen-based population screening in Kanazawa city, Japan;Kitagawa;Int. J. Urol.,2011

4. Free-to-total prostate-specific antigen (PSA) ratio contributes to an increased rate of prostate cancer detection in a Japanese population screened using a PSA level of 2.1-10.0 ng/ml as a criterion;Kobori;Int. J. Clin. Oncol.,2008

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of PSA variability with prostate cancer development using large-scale medical information data: a retrospective cohort study;Genes and Environment;2023-10-17

2. No association of serum PSA with vitamin D or total oxidant-antioxidant capacity in healthy men;The Aging Male;2018-08-07

3. L ong‐term longitudinal changes in baseline PSA distribution and estimated prevalence of prostate cancer in male Japanese participants of population‐based PSA screening;International Journal of Cancer;2018-05-14

4. Editorial Comment to Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL;International Journal of Urology;2017-06-21

5. Predictive value of different prostate-specific antigen-based markers in men with baseline total prostate-specific antigen <2.0 ng/mL;International Journal of Urology;2017-05-31